Provided by Tiger Trade Technology Pte. Ltd.

ZHAOKE OPHTH-B

2.530
0.000
Volume:69.50K
Turnover:175.63K
Market Cap:1.39B
PE:-6.62
High:2.550
Open:2.525
Low:2.510
Close:2.530
52wk High:4.280
52wk Low:2.380
Shares:549.00M
HK Float Shares:549.00M
Volume Ratio:0.55
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.382
ROE:-12.02%
ROA:-8.17%
PB:0.76
PE(LYR):-6.62
PS:37.23

Loading ...

Hong Kong Stock Movers: Lee's Pharm Surges Over 7% After ZK2401 IND Accepted by China's NMPA

Stock News
·
Aug 14

Zhaoke Ophthalmology Enters 5-Year Exclusive Mainland China Distribution Agreement with Pharmentum Biopharma for Epinastine Eye Drops

Bulletin Express
·
Aug 12

Zhaoke Ophthalmology Signs Exclusive Distribution Deal with Pharmentum Biopharma for Epinastine Eye Drops in China

Reuters
·
Aug 12

Zhaoke Ophthalmology - Enters Exclusive Distribution Agreement with Pharmentum Biopharma in China

THOMSON REUTERS
·
Aug 12

Zhaoke Ophthalmology - Agreement to Commercialize Epinastine Hydrochloride Eye Drops in China (Excluding Hong Kong, Macau and Taiwan)

THOMSON REUTERS
·
Aug 12

Zhaoke Ophthalmology: No Change in Issued Shares for July 2026; 66.50 k Shares Await Cancellation After Buy-back

Bulletin Express
·
Aug 03

Zhaoke Ophthalmology secures Macau clearance for innovative presbyopia therapy YUVEZZI™

Bulletin Express
·
Jul 20

Innovative Presbyopia Treatment YUVEZZI™ from Zhaoke Ophthalmology Receives Approval in Macau

Stock News
·
Jul 20

Zhaoke Ophthalmology - Yuvezzitm Approved by Macau Pharmaceutical Administration Bureau for Presbyopia Treatment

THOMSON REUTERS
·
Jul 20

Zhaoke Ophthalmology Says Macau Regulator Approves Presbyopia Eye Drop Yuvezzi

Reuters
·
Jul 20

Lee's Pharmaceutical Enters Exclusive Licensing and Supply Deal for Interferon Alpha-2b Outside Greater China

Stock News
·
Jul 17

Key Corporate Updates from Hong Kong-Listed Companies: Strategic Alliances, Financial Results, and Regulatory Milestones

Stock News
·
Jul 14

Zhaoke Ophthalmology acquires global rights to pediatric-myopia drug NVK002

Bulletin Express
·
Jul 13

Zhaoke Ophthalmology-B Secures Worldwide Rights for NVK002 Atropine Sulfate Eye Drops

Stock News
·
Jul 13

Zhaoke Ophthalmology Ltd - Entered into Definitive Agreement for Acquisition of Global Rights to Nvk002

THOMSON REUTERS
·
Jul 13

Zhaoke Ophthalmology - Grants Perpetual Royalty-free Exclusive U.S. Nvk002 License to Nevakar Pharmaceuticals

THOMSON REUTERS
·
Jul 13

Zhaoke Ophthalmology: Cumulative Share Buybacks Reach 1.72 Million Shares, Representing 0.31% of Issued Capital

Bulletin Express
·
Jul 09

Zhaoke Ophthalmology-B (06622) Repurchases 8,500 Shares for HK$22,100 on July 9

Stock News
·
Jul 09

Zhaoke Ophthalmology-B's Innovative Presbyopia Treatment YUVEZZI™ Approved for Import and Use at Boao Super Hospital

Stock News
·
Jul 07

Zhaoke Ophthalmology Gains Hainan Approval for YUVEZZI™, China’s First Innovative Presbyopia Therapy

Bulletin Express
·
Jul 07